{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:25:23Z","timestamp":1765545923011},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T00:00:00Z","timestamp":1403827200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0101063","type":"journal-article","created":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T20:30:01Z","timestamp":1403901001000},"page":"e101063","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Vascular Endothelial Growth Factor A (VEGFA) Gene Polymorphisms Have an Impact on Survival in a Subgroup of Indolent Patients with Chronic Lymphocytic Leukemia"],"prefix":"10.1371","volume":"9","author":[{"given":"Carol","family":"Lozano-Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimena","family":"Martinez-Velasquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belen","family":"Fernandez-Cuevas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natividad","family":"Polo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belen","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Millan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Miguel","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Collado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Sanchez-Godoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Carbonell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Antonio","family":"Garcia-Vela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Antonio","family":"Garcia-Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Gomez-Lozano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,6,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.leukres.2009.06.023","article-title":"Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF","volume":"34","author":"R Maffei","year":"2010","journal-title":"Leuk Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/sj.leu.2401825","article-title":"Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia","volume":"14","author":"AR Kini","year":"2000","journal-title":"Leukemia"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1182\/blood.V97.8.2529","article-title":"Angiogenesis is increased in B-cell chronic lymphocytic leukemia","volume":"97","author":"L Peterson","year":"2001","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/sj.leu.2403631","article-title":"Autocrine VEGF mediates the antiapoptotic effect of CD154 on CLL cells","volume":"19","author":"M Farahani","year":"2005","journal-title":"Leukemia"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Bairey O, Boycov O, Kaganovsky E, Zimra Y, Shaklai M, <etal>et al<\/etal>. (2004) All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells. Leuk Res 28: 243\u2013248. S014521260300256X [pii].","DOI":"10.1016\/S0145-2126(03)00256-X"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1182\/blood-2003-08-2763","article-title":"VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia","volume":"104","author":"YK Lee","year":"2004","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2119\/molmed.2010.00210","article-title":"Bone marrow stromal cell-derived vascular endothelial growth factor (VEGF) rather than chronic lymphocytic leukemia (CLL) cell-derived VEGF is essential for the apoptotic resistance of cultured CLL cells","volume":"17","author":"I Gehrke","year":"2011","journal-title":"Mol Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1182\/blood-2004-10-4054","article-title":"CLL, but not normal, B cells are dependent on autocrine VEGF and alpha4beta1 integrin for chemokine-induced motility on and through endothelium","volume":"105","author":"KJ Till","year":"2005","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1182\/blood-2009-08-239426","article-title":"VEGF\/VEGFR2 interaction down-regulates matrix metalloproteinase-9 via STAT1 activation and inhibits B chronic lymphocytic leukemia cell migration","volume":"115","author":"E Ugarte-Berzal","year":"2010","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.leukres.2008.03.003","article-title":"Bone marrow fibroblasts induce expression of PI3K\/NF-kappaB pathway genes and a pro-angiogenic phenotype in CLL cells","volume":"32","author":"J Edelmann","year":"2008","journal-title":"Leuk Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2009-09-242719","article-title":"Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression","volume":"115","author":"AK Ghosh","year":"2010","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Molica S, Vitelli G, Levato D, Gandolfo GM, Liso V (1999) Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia. Br J Haematol 107: 605\u2013610. bjh1752 [pii].","DOI":"10.1046\/j.1365-2141.1999.01752.x"},{"key":"ref13","first-page":"41","article-title":"Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia","volume":"16","author":"J Gora-Tybor","year":"2005","journal-title":"Eur Cytokine Netw"},{"key":"ref14","first-page":"795","article-title":"High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia","volume":"7","author":"A Ferrajoli","year":"2001","journal-title":"Clin Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.lungcan.2004.04.037","article-title":"VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer","volume":"46","author":"MI Koukourakis","year":"2004","journal-title":"Lung Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"H1848","DOI":"10.1152\/ajpheart.01033.2005","article-title":"DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption","volume":"290","author":"SJ Prior","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E (2000) A common 936 C\/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37: 443\u2013448. 54076 [pii];54076 [doi].","DOI":"10.1159\/000054076"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1006\/cyto.2000.0692","article-title":"Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production","volume":"12","author":"CJ Watson","year":"2000","journal-title":"Cytokine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2337\/diabetes.51.5.1635","article-title":"A common polymorphism in the 5\u2032-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes","volume":"51","author":"T Awata","year":"2002","journal-title":"Diabetes"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V, <etal>et al<\/etal>. (1999) Novel polymorphisms in the promoter and 5\u2032 UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 60: 1245\u20131249. S0198-8859(99)00132-9 [pii].","DOI":"10.1016\/S0198-8859(99)00132-9"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00432-009-0714-1","article-title":"The importance of \u2212460 C\/T and +405 G\/C single nucleotide polymorphisms to the function of vascular endothelial growth factor A in colorectal cancer","volume":"136","author":"TF Hansen","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1158\/1535-7163.MCT-09-0302","article-title":"The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors","volume":"8","author":"L Jain","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref23","first-page":"812","article-title":"Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter","volume":"63","author":"A Stevens","year":"2003","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","article-title":"National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment","volume":"87","author":"BD Cheson","year":"1996","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood-2012-09-458265","article-title":"Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia","volume":"121","author":"D Rossi","year":"2013","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.leu.2404457","article-title":"ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia","volume":"21","author":"P Ghia","year":"2007","journal-title":"Leukemia"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/319501","article-title":"A new statistical method for haplotype reconstruction from population data","volume":"68","author":"M Stephens","year":"2001","journal-title":"Am J Hum Genet"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Freathy RM, Weedon MN, Shields B, Hitman GA, Walker M, <etal>et al<\/etal>. (2006) Functional variation in VEGF is not associated with type 2 diabetes in a United Kingdom Caucasian population. JOP 7: 295\u2013302. v07i03a05 [pii].","DOI":"10.1186\/1471-2350-7-51"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1097\/01.tp.0000250656.33731.08","article-title":"Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic groups of pediatric heart transplant patients","volume":"82","author":"DM Girnita","year":"2006","journal-title":"Transplantation"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s12032-013-0456-4","article-title":"VEGF and bFGF gene polymorphisms in Polish patients with B-CLL","volume":"30","author":"T Wrobel","year":"2013","journal-title":"Med Oncol"},{"key":"ref31","first-page":"687","article-title":"Highly purified CD38+ and","volume":"21","author":"C Pepper","year":"2007","journal-title":"Leukemia"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V96.6.2240","article-title":"Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes","volume":"96","author":"A Aguayo","year":"2000","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood.V95.1.309","article-title":"Evidence of increased angiogenesis in patients with acute myeloid leukemia","volume":"95","author":"JW Hussong","year":"2000","journal-title":"Blood"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2141.2007.06887.x","article-title":"Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukaemia patients","volume":"140","author":"DH Kim","year":"2008","journal-title":"Br J Haematol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/annonc\/mdp452","article-title":"Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy","volume":"21","author":"DH Kim","year":"2010","journal-title":"Ann Oncol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00432-009-0650-0","article-title":"Association of VEGF genetic polymorphisms with the clinical characteristics of non-Hodgkin\u2019s lymphoma","volume":"135","author":"LP Diao","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"159813","DOI":"10.1155\/2013\/159813","article-title":"VEGF and bFGF gene polymorphisms in patients with Non-Hodgkin\u2019s lymphoma","volume":"2013","author":"T Wrobel","year":"2013","journal-title":"BioMed Research International"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.3109\/10428194.2010.524327","article-title":"Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia","volume":"51","author":"T Shanafelt","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1365-2141.2009.07811.x","article-title":"Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia","volume":"146","author":"TD Shanafelt","year":"2009","journal-title":"Br J Haematol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0101063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T03:07:49Z","timestamp":1716865669000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0101063"}},"subtitle":[],"editor":[{"given":"Masaru","family":"Katoh","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,27]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0101063","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,27]]}}}